CVRx, Inc.(CVRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVRX CVRx, Inc.

盘后交易 09-24 19:37:05 EDT

2.53

-0.19

-6.99%

盘后2.54

+0.01+0.40%

19:30 EDT

最高2.73	最低2.51	成交量69.37万
今开2.73	昨收2.72	日振幅8.09%
总市值6,740万	流通市值3,934万	总股本2,664万
成交额178.02万	换手率4.46%	流通股本1,555万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVRX","market":"US","secType":"STK","nameCN":"CVRx, Inc.","latestPrice":2.53,"timestamp":1790280000000,"preClose":2.72,"halted":0,"volume":693685,"hourTrading":{"tag":"盘后","latestPrice":2.54,"preClose":2.53,"latestTime":"19:30 EDT","volume":13318,"amount":34095.0415596,"timestamp":1790292604532,"change":0.01,"changeRate":0.003953,"amplitude":0.01581},"delay":0,"changeRate":-0.06985294117647073,"floatShares":15550100,"shares":26641597,"eps":-1.9748,"marketStatus":"盘后交易","change":-0.19,"latestTime":"09-24 19:37:05 EDT","open":2.73,"high":2.73,"low":2.51,"amount":1780179.5365250001,"amplitude":0.080882,"askPrice":2.56,"askSize":9,"bidPrice":2.53,"bidSize":20,"shortable":3,"etf":0,"ttmEps":-1.9748,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1790294400000},"marketStatusCode":4,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":2.72,"preHourTrading":{"tag":"盘前","latestPrice":2.73,"preClose":2.72,"latestTime":"08:45 EDT","volume":2259,"amount":6217.2600102,"timestamp":1790253934257,"change":0.01,"changeRate":0.003676,"amplitude":0.044118},"postHourTrading":{"tag":"盘后","latestPrice":2.54,"preClose":2.53,"latestTime":"19:30 EDT","volume":13318,"amount":34095.0415596,"timestamp":1790292604532,"change":0.01,"changeRate":0.003953,"amplitude":0.01581},"volumeRatio":1.360392,"impliedVol":0.3494,"impliedVolPercentile":0.0637},"requestUrl":"/m/hq/s/CVRX","defaultTab":"news","newsList":[{"id":"1193167163","title":"持有CVRx逾5.5%流通股的Jorey Chernett敦促董事会即刻启动出售程序，寻求战略收购方","url":"https://stock-news.laohu8.com/highlight/detail?id=1193167163","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193167163?lang=zh_cn&edition=full","pubTime":"2026-08-24 20:31","pubTimestamp":1787574674,"startTime":"0","endTime":"0","summary":"Jorey Chernett，这位持有CVRx, Inc.超过5.5%流通股的股东，正强势发声——他公开呼吁公司董事会立即开启出售流程，目标直指战略收购方。Chernett的立场清晰而坚定：董事会应当马上采取行动，而非在观望中错失良机。CVRx, Inc.，这家专注于创新医疗技术领域的企业，如今站在了一个关键的十字路口。Chernett的公开表态，无疑为市场注入了新的变量。市场将密切关注CVRx董事会的下一步动作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4539","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195018165","title":"CVRx首席营收官Robert John于2026年8月10日被解职——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1195018165","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195018165?lang=zh_cn&edition=full","pubTime":"2026-08-11 19:11","pubTimestamp":1786446670,"startTime":"0","endTime":"0","summary":"CVRx, Inc. 近日在提交给美国证券交易委员会（SEC）的文件中披露，首席营收官Robert John的雇佣关系已于2026年8月10日正式终止。这一决定，来得突然，也颇为引人注目。毕竟，在公司的营收战略中，他扮演着关键角色。然而，SEC文件并未就解职的具体原因，提供任何额外的解释或说明。市场对此消息，显然需要时间来消化和评估其潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124717725","title":"CVRx, Inc.发布2026财年业绩指引：营收预期6300万至6700万美元，毛利率85%-87%，运营支出1.03亿至1.07亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124717725","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124717725?lang=zh_cn&edition=full","pubTime":"2026-05-12 04:21","pubTimestamp":1778530892,"startTime":"0","endTime":"0","summary":"医疗设备公司CVRx, Inc.公布了其2026财年的业绩指引。公司预计，全年总营收将在6300万至6700万美元之间。在盈利能力方面，公司给出了85%至87%的毛利率预期，显示出对产品组合盈利能力的信心。与此同时，公司预计全年的运营支出将达到1.03亿至1.07亿美元，这一数字反映了公司在研发、销售及市场推广等方面的持续投入规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105849032","title":"CVRx启动Benefit-HF里程碑心衰试验首例患者入组 Barostim疗法适应人群大幅扩展","url":"https://stock-news.laohu8.com/highlight/detail?id=1105849032","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105849032?lang=zh_cn&edition=full","pubTime":"2026-05-05 04:33","pubTimestamp":1777926783,"startTime":"0","endTime":"0","summary":"CVRx公司宣布其具有里程碑意义的心力衰竭临床试验Benefit-HF已完成首例患者入组。该项研究将评估Barostim神经调节装置在显著扩大适应人群中的疗效，标志着该疗法向更广泛心衰患者群体应用迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4082","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518788359","title":"Cvrx, Inc.盘中异动 下午盘快速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518788359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518788359?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:07","pubTimestamp":1741630074,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时07分，Cvrx, Inc.股票出现波动，股价快速跳水5.19%。Cvrx, Inc.股票所在的医疗器械行业中，整体跌幅为1.41%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102075496406ce8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102075496406ce8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVRX","BK4082","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517194305","title":"Cvrx, Inc.盘中异动 股价大跌5.05%报11.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517194305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517194305?lang=zh_cn&edition=full","pubTime":"2025-03-07 02:45","pubTimestamp":1741286734,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日02时45分，Cvrx, Inc.股票出现波动，股价快速跳水5.05%。截至发稿，该股报11.85美元/股，成交量3.9388万股，换手率0.15%，振幅5.05%。Cvrx, Inc.股票所在的医疗器械行业中，整体跌幅为2.43%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307024534989ee10e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307024534989ee10e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","CVRX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516704276","title":"Cvrx, Inc.盘中异动 早盘快速下挫5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516704276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516704276?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:04","pubTimestamp":1741100650,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时04分，Cvrx, Inc.股票出现波动，股价快速下跌5.39%。Cvrx, Inc.股票所在的医疗器械行业中，整体跌幅为0.53%。其相关个股中，908 Devices Inc.、Nexalin Technology Inc C/Wts 、Envoy Medical Inc C/Wts 29/09/2028 涨幅较大，908 Devices Inc.、Reshape Lifesciences, Inc.、Venus Concept Inc.较为活跃，换手率分别为120.77%、8.46%、8.40%，振幅较大的相关个股有Profound Medical Corp.、908 Devices Inc.、Venus Concept Inc.，振幅分别为102.86%、35.35%、23.97%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304230410989bb5be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304230410989bb5be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVRX","BK4082","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516663918","title":"Cvrx, Inc.盘中异动 快速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516663918?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:06","pubTimestamp":1741032417,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时06分，Cvrx, Inc.股票出现异动，股价快速下挫5.02%。Cvrx, Inc.股票所在的医疗器械行业中，整体涨幅为0.73%。其相关个股中，Adagio Medical Holdings, Inc、Senseonics Holdings, Inc.、Ceribell, Inc.涨幅较大，Reshape Lifesciences, Inc.、Sintx Technologies, Inc.、Bluejay Diagnostics, Inc.较为活跃，换手率分别为49.68%、18.39%、12.46%，振幅较大的相关个股有Nexalin Technology Inc C/Wts 、Ainos Inc C/Wts 29/07/2027 、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 ，振幅分别为71.96%、59.09%、40.86%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040406579637f73b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040406579637f73b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CVRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514358138","title":"Cvrx, Inc.盘中异动 临近收盘股价大跌5.04%报13.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514358138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514358138?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:58","pubTimestamp":1740689928,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时58分，Cvrx, Inc.股票出现波动，股价快速跳水5.04%。截至发稿，该股报13.00美元/股，成交量8.6189万股，换手率0.33%，振幅5.95%。Cvrx, Inc.股票所在的医疗器械行业中，整体跌幅为0.77%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045848abdfc336&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045848abdfc336&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CVRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514852435","title":"Cvrx, Inc.盘中异动 早盘股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514852435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514852435?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:52","pubTimestamp":1740585175,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时52分，Cvrx, Inc.股票出现异动，股价大幅拉升5.14%。截至发稿，该股报13.90美元/股，成交量3.916万股，换手率0.15%，振幅4.54%。Cvrx, Inc.股票所在的医疗器械行业中，整体涨幅为0.87%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226235255a25509f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226235255a25509f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVRX","BK4082","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514182990","title":"Cvrx, Inc.盘中异动 股价大涨5.93%报13.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514182990","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514182990?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:59","pubTimestamp":1740495581,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时59分，Cvrx, Inc.股票出现波动，股价急速拉升5.93%。截至发稿，该股报13.94美元/股，成交量13.9917万股，换手率0.54%，振幅6.08%。Cvrx, Inc.股票所在的医疗器械行业中，整体跌幅为0.22%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225941962ff91b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225941962ff91b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511692931","title":"Cvrx, Inc.盘中异动 早盘股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511692931?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:59","pubTimestamp":1739548759,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时59分，Cvrx, Inc.股票出现波动，股价大幅拉升5.31%。Cvrx, Inc.股票所在的医疗器械行业中，整体跌幅为0.20%。其相关个股中，Pacific Biosciences Of California, Inc.、Avita Medical, Inc.、Envoy Medical Inc C/Wts 29/09/2028 涨幅较大，Nanovibronix, Inc.、Tivic Health Systems, Inc.、Nano-X Imaging Ltd较为活跃，换手率分别为211.89%、54.78%、10.81%，振幅较大的相关个股有Nanovibronix, Inc.、Pacific Biosciences Of California, Inc.、Nexalin Technology Inc C/Wts ，振幅分别为58.22%、42.23%、34.76%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423591998859e73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423591998859e73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVRX","BK4539","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509030722","title":"Cvrx, Inc.2024财年实现净利润-59.97百万美元，同比减少45.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509030722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509030722?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:00","pubTimestamp":1738857639,"startTime":"0","endTime":"0","summary":"2月7日，Cvrx, Inc.公布财报，公告显示公司2024财年净利润为-59.97百万美元，同比减少45.56%；其中营业收入为51.29百万美元，同比增加30.51%，每股基本收益为-2.65美元。从资产负债表来看，Cvrx, Inc.总负债62.36百万美元，其中短期债务--，资产负债比为0.03，流动比率为0.13。机构评级：截至2025年2月7日，当前有6家机构对Cvrx, Inc.目标价做出预测，其中目标均价为19.83美元，其中最低目标价为15.00美元，最高目标价为23.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207000052a23be272&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207000052a23be272&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509203077","title":"Cvrx, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509203077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509203077?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:59","pubTimestamp":1738857557,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时59分，Cvrx, Inc.股票出现波动，股价大幅下挫5.17%。截至发稿，该股报14.30美元/股，成交量6.2444万股，换手率0.25%，振幅5.37%。Cvrx, Inc.股票所在的医疗器械行业中，整体跌幅为0.41%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206235917987c9ceb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206235917987c9ceb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4082","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509231048","title":"Piper Sandler：维持CVRx(CVRX.US)评级，由增持调整至增持评级, 目标价由16.00美元调整至20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509231048","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509231048?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:25","pubTimestamp":1738776342,"startTime":"0","endTime":"0","summary":"Piper Sandler：维持CVRx(CVRX.US)评级，由增持调整至增持评级, 目标价由16.00美元调整至20.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/06012547975232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181292575","title":"CVRx 第四季度每股收益 $(0.43) 不及预期 $(0.38)，销售额 $1534 万超过预期 $1506 万","url":"https://stock-news.laohu8.com/highlight/detail?id=1181292575","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181292575?lang=zh_cn&edition=full","pubTime":"2025-02-05 05:10","pubTimestamp":1738703445,"startTime":"0","endTime":"0","summary":"CVRx  报告季度每股亏损 $，低于分析师共识预期的 $，低 13.16%。这是相比去年同期每股亏损 $ 增长了 2.27%。公司报告季度销售额为 1534 万美元，高于分析师预期的 1506 万美元，高 1.86%。以上内容来自Benzinga Earnings专栏，原文如下：CVRx  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 13.16 percent. This is a 2.27 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $15.34 million which beat the analyst consensus estimate of $15.06 million by 1.86 percent.  This is a 35.71 perc","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CVRx 第四季度每股收益 $(0.43) 不及预期 $(0.38)，销售额 $1534 万超过预期 $1506 万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508450213","title":"Cvrx, Inc.盘中异动 股价大涨5.17%报16.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508450213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508450213?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:48","pubTimestamp":1738680503,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时48分，Cvrx, Inc.股票出现异动，股价快速上涨5.17%。截至发稿，该股报16.26美元/股，成交量9877股，换手率0.04%，振幅6.27%。Cvrx, Inc.股票所在的医疗器械行业中，整体跌幅为0.13%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224823abc22b96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204224823abc22b96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4082","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508599758","title":"Cvrx, Inc.盘中异动 临近收盘大幅跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508599758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508599758?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:45","pubTimestamp":1738356313,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时45分，Cvrx, Inc.股票出现波动，股价快速下挫5.05%。Cvrx, Inc.股票所在的医疗器械行业中，整体跌幅为0.25%。其相关个股中，Biosig Technologies, Inc.、Sensus Healthcare, Inc.、Dih Holdings Us Inc C/Wts 20/04/2028 涨幅较大，Nanovibronix, Inc.、Nuwellis, Inc.、Helius Medical Technologies, Inc.较为活跃，换手率分别为56.94%、41.02%、16.86%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Tenon Medical Inc C/Wts 16/06/2028 、Nuwellis, Inc.，振幅分别为77.88%、50.27%、28.80%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020104451396151596&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020104451396151596&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4082","CVRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507568466","title":"Cvrx, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507568466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507568466?lang=zh_cn&edition=full","pubTime":"2025-01-30 01:06","pubTimestamp":1738170396,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日01时06分，Cvrx, Inc.股票出现异动，股价大幅下跌5.02%。截至发稿，该股报16.45美元/股，成交量6.1981万股，换手率0.26%，振幅5.92%。Cvrx, Inc.股票所在的医疗器械行业中，整体跌幅为0.33%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501300106369613a7ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501300106369613a7ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CVRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507254005","title":"Cvrx, Inc.盘中异动 股价大涨5.07%报17.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507254005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507254005?lang=zh_cn&edition=full","pubTime":"2025-01-29 04:58","pubTimestamp":1738097929,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日04时58分，Cvrx, Inc.股票出现异动，股价急速上涨5.07%。截至发稿，该股报17.41美元/股，成交量16.2132万股，换手率0.67%，振幅6.00%。Cvrx, Inc.股票所在的医疗器械行业中，整体跌幅为0.52%。Cvrx, Inc.公司简介：CVRx Inc 是一家商业阶段的医疗器械公司，专注于为心血管疾病患者开发、制造和商业化微创神经调节解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129045850987593e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129045850987593e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVRX","BK4082","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cvrx.com","stockEarnings":[{"period":"1week","weight":-0.0993},{"period":"1month","weight":-0.1365},{"period":"3month","weight":-0.4819},{"period":"6month","weight":-0.6947},{"period":"1year","weight":-0.6349},{"period":"ytd","weight":-0.6169}],"compareEarnings":[{"period":"1week","weight":0.0182},{"period":"1month","weight":0.0057},{"period":"3month","weight":0.0456},{"period":"6month","weight":0.2109},{"period":"1year","weight":0.1577},{"period":"ytd","weight":0.126}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CVRx, Inc.于2000年8月在特拉华州注册成立，是一家商业阶段的医疗器械公司，致力于为心血管疾病患者开发、制造创新的神经调节解决方案并将其商业化。该公司的旗舰产品Barostim是美国食品药品监督管理局（FDA）批准的首个利用神经调节缓解心力衰竭（HF）症状的医疗技术。这种可植入设备有助于改善大脑自主神经系统（ANS）中的信号传导，以抵消HF的不利影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.093597},{"month":2,"riseRate":0.4,"avgChangeRate":-0.085377},{"month":3,"riseRate":0.2,"avgChangeRate":-0.089798},{"month":4,"riseRate":0.4,"avgChangeRate":-0.093376},{"month":5,"riseRate":0.2,"avgChangeRate":-0.166016},{"month":6,"riseRate":0.4,"avgChangeRate":0.146711},{"month":7,"riseRate":0.666667,"avgChangeRate":0.068189},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.089059},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.021752},{"month":10,"riseRate":0.8,"avgChangeRate":0.147336},{"month":11,"riseRate":0.6,"avgChangeRate":0.134494},{"month":12,"riseRate":0.6,"avgChangeRate":0.102852}],"exchange":"NASDAQ","name":"CVRx, Inc.","nameEN":"CVRx, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CVRx, Inc.(CVRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CVRx, Inc.(CVRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CVRx, Inc.,CVRX,CVRx, Inc.股票,CVRx, Inc.股票老虎,CVRx, Inc.股票老虎国际,CVRx, Inc.行情,CVRx, Inc.股票行情,CVRx, Inc.股价,CVRx, Inc.股市,CVRx, Inc.股票价格,CVRx, Inc.股票交易,CVRx, Inc.股票购买,CVRx, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CVRx, Inc.(CVRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CVRx, Inc.(CVRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}